Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Douglas Weaver

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|September 19, 2003
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trialLars Wallentin, Robert G Wilcox, W Douglas Weaver, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Cost analysis of endovenous catheter ablation versus surgical stripping for treatment of superficial venous insufficiency and varicose vein diseaseJudith C Lin, David R Nerenz, Pauline Migliore, et al.
The Journal of Invasive Cardiology|May 10, 2005
Long-term outcomes based on time-to-angioplasty in patients admitted with non-ST-segment elevation acute coronary syndromesMouaz Al-Mallah, Khaled Dajani, Michael Hudson, et al.
Journal of Interventional Cardiology|September 20, 2002
Resource utilization, cost, and health status impacts of coronary stent versus "optimal" percutaneous coronary angioplasty: results from the OPUS-I trialNancy Neil, Scott D Ramsey, David J Cohen, et al.
Journal of the American College of Cardiology|January 5, 2002
Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) studyPeter A McCullough, Edward F Philbin, John A Spertus, et al.
The American Journal of Medicine|October 27, 2004
Misdiagnosis of atrial fibrillation and its clinical consequencesFrank Bogun, Daejoon Anh, Gautham Kalahasty, et al.
Heart (British Cardiac Society)|January 17, 2013
The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary interventionIssam Moussa, Anthony Hermann, John C Messenger, et al.
Clinical Cardiology|November 24, 2004
Dyslipidemia in patients with angiographically confirmed coronary artery disease--an opportunity for improvementSanjaya Khanal, Omar Obeidat, Mei Lu, et al.
Current Controlled Trials in Cardiovascular Medicine|August 24, 2005
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarctionAslan T Turer, Kenneth W Mahaffey, Dianne Gallup, et al.
CJEM|July 5, 2007
Diagnostic parameters of CK-MB and myoglobin related to chest pain durationGrant Innes, James Christenson, W Douglas Weaver, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|September 19, 2003
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trialLars Wallentin, Robert G Wilcox, W Douglas Weaver, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Cost analysis of endovenous catheter ablation versus surgical stripping for treatment of superficial venous insufficiency and varicose vein diseaseJudith C Lin, David R Nerenz, Pauline Migliore, et al.
The Journal of Invasive Cardiology|May 10, 2005
Long-term outcomes based on time-to-angioplasty in patients admitted with non-ST-segment elevation acute coronary syndromesMouaz Al-Mallah, Khaled Dajani, Michael Hudson, et al.
Journal of Interventional Cardiology|September 20, 2002
Resource utilization, cost, and health status impacts of coronary stent versus "optimal" percutaneous coronary angioplasty: results from the OPUS-I trialNancy Neil, Scott D Ramsey, David J Cohen, et al.
Journal of the American College of Cardiology|January 5, 2002
Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) studyPeter A McCullough, Edward F Philbin, John A Spertus, et al.
The American Journal of Medicine|October 27, 2004
Misdiagnosis of atrial fibrillation and its clinical consequencesFrank Bogun, Daejoon Anh, Gautham Kalahasty, et al.
Heart (British Cardiac Society)|January 17, 2013
The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary interventionIssam Moussa, Anthony Hermann, John C Messenger, et al.
Clinical Cardiology|November 24, 2004
Dyslipidemia in patients with angiographically confirmed coronary artery disease--an opportunity for improvementSanjaya Khanal, Omar Obeidat, Mei Lu, et al.
Current Controlled Trials in Cardiovascular Medicine|August 24, 2005
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarctionAslan T Turer, Kenneth W Mahaffey, Dianne Gallup, et al.
CJEM|July 5, 2007
Diagnostic parameters of CK-MB and myoglobin related to chest pain durationGrant Innes, James Christenson, W Douglas Weaver, et al.
Pageof 9